{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:05:35Z","timestamp":1790665535543,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T00:00:00Z","timestamp":1556928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"No","award":["No"],"award-info":[{"award-number":["No"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1075-8","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T14:33:19Z","timestamp":1557153199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium"],"prefix":"10.1186","volume":"14","author":[{"given":"Liese","family":"Vandeborne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"van Overbeeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1709-087X","authenticated-orcid":false,"given":"Marc","family":"Dooms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"De Beleyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Huys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,4]]},"reference":[{"key":"1075_CR1","volume-title":"De zorg voor het kind door de huisarts en de pediater [dissertation]","author":"H De Sadeleer","year":"2016","unstructured":"De Sadeleer H. De zorg voor het kind door de huisarts en de pediater [dissertation]. Ghent: University of Ghent; 2016."},{"issue":"1","key":"1075_CR2","first-page":"17","volume":"36","author":"FL McIntyre","year":"1993","unstructured":"McIntyre FL. One in a million: when extraordinary cases occur in an ordinary practice. J Fam Pract. 1993;36(1):17\u20138.","journal-title":"J Fam Pract"},{"key":"1075_CR3","volume-title":"Rare disease: taking a different approach","author":"Cello Health","year":"2016","unstructured":"Cello Health. Rare disease: taking a different approach. 2016. Available from: http:\/\/www.pharmavoice.com\/wp-content\/uploads\/wp-CelloHealth-081516.pdf?tracker_id=1481649315 ."},{"issue":"7","key":"1075_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1157\/13087370","volume":"37","author":"M Garcia-Ribes","year":"2006","unstructured":"Garcia-Ribes M, Ejarque I, Arenas E, Martin V. New challenges: general practitioners faced with \u201crare diseases\u201d. Aten Primaria. 2006;37(7):369\u201370.","journal-title":"Aten Primaria"},{"key":"1075_CR5","volume-title":"The voice of 12,000 patients. Experiences and expectations of rare disease patients on diagnosis and Care in Europe","author":"A Kole","year":"2009","unstructured":"Kole A, Faurisson F, Mavris M. The voice of 12,000 patients. Experiences and expectations of rare disease patients on diagnosis and Care in Europe. Paris: EURORDIS; 2009."},{"key":"1075_CR6","volume-title":"Training module transthyretin familial amyloid polyneuropathy (TTR-FAP) [for training purposes only. For internal use only.]","author":"Pfizer Inc","year":"2011","unstructured":"Pfizer Inc. Training module transthyretin familial amyloid polyneuropathy (TTR-FAP) [for training purposes only. For internal use only.]. 2011."},{"issue":"2","key":"1075_CR7","first-page":"1","volume":"1","author":"P Engel","year":"2013","unstructured":"Engel P, Bagal A, Broback M, Boice N. Physician and patient perceptions regarding physician training in rare diseases: the need for stronger educational initiatives for physicians. J Rare Disord. 2013;1(2):1\u201315.","journal-title":"J Rare Disord"},{"issue":"3","key":"1075_CR8","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.jpeds.2005.08.011","volume":"147","author":"M Kharrazi","year":"2005","unstructured":"Kharrazi M, Kharrazi LD. Delayed diagnosis of cystic fibrosis and the family perspective. J Pediatr. 2005;147(3 Suppl):S21\u20135.","journal-title":"J Pediatr"},{"issue":"Suppl 1","key":"1075_CR9","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/WCO.0000000000000289","volume":"29","author":"D Adams","year":"2016","unstructured":"Adams D, Suhr OB, Hund E, Obici L, Tournev I, Campistol JM, et al. First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Curr Opin Neurol. 2016;29(Suppl 1):S14\u201326.","journal-title":"Curr Opin Neurol"},{"key":"1075_CR10","volume-title":"Rare disease impact report: insights from patients and the medical community","author":"ISEBOX Ltd\/Shire","year":"2013","unstructured":"ISEBOX Ltd\/Shire. Rare disease impact report: insights from patients and the medical community 2013."},{"key":"1075_CR11","volume-title":"Reality - an insight into the patient and family experience of rare disease","author":"E Muir","year":"2016","unstructured":"Muir E. Reality - an insight into the patient and family experience of rare disease. London: Rare Disease UK for Genetic Alliance UK; 2016."},{"key":"1075_CR12","unstructured":"Koning Boudewijnstichting (KBS). ZOOM zeldzame ziekten: nieuwe perspectieven op gelijke kansen. Brussel: Koning Boudewijnstichting; 2014. Available from: https:\/\/en.calameo.com\/read\/001774295050dd649b312?authid=bVhUQGuPkXoR ."},{"key":"1075_CR13","unstructured":"Miteva T, Jordanova R, Iskrov G, Stefanov R. General knowledge and awareness on rare diseases among general practitioners in Bulgaria. Georgian Med News. 2011;(193):16\u20139."},{"key":"1075_CR14","first-page":"e23579","volume":"1","author":"S Bavisetty","year":"2013","unstructured":"Bavisetty S, Grody WW, Yazdani S. Emergence of pediatric rare diseases: review of present policies and opportunities for improvement. Rare Dis (Austin, Tex). 2013;1:e23579.","journal-title":"Rare Dis (Austin, Tex)"},{"issue":"582","key":"1075_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3399\/bjgp11X548974","volume":"61","author":"F Buntinx","year":"2011","unstructured":"Buntinx F, Mant D, Van den Bruel A, Donner-Banzhof N, Dinant GJ. Dealing with low-incidence serious diseases in general practice. Br J Gen Pract: the journal of the Royal College of General Practitioners. 2011;61(582):43\u20136.","journal-title":"Br J Gen Pract: the journal of the Royal College of General Practitioners"},{"issue":"1\u20132","key":"1075_CR16","first-page":"59","volume":"49","author":"D Taruscio","year":"2007","unstructured":"Taruscio D, Trama A, Stefanov R. Tackling rare diseases at European level: why do we need a harmonized framework? Folia Med. 2007;49(1\u20132):59\u201367.","journal-title":"Folia Med"},{"issue":"6","key":"1075_CR17","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1542\/peds.62.6.1056","volume":"62","author":"NA Holtzman","year":"1978","unstructured":"Holtzman NA. Rare diseases, common problems: recognition and management. Pediatrics. 1978;62(6):1056\u201360.","journal-title":"Pediatrics."},{"key":"1075_CR18","volume-title":"A survey about rare diseases among Swedish general practitioners [dissertation] [personal communication]","author":"D Gavhed","year":"2012","unstructured":"Gavhed D, Thorarinsson K, Lindb\u00e4ck J, Larsson A, Henter JI. A survey about rare diseases among Swedish general practitioners [dissertation] [personal communication]. Stockholm: Karolinska Institutet, Karolinska University Hospital; 2012."},{"issue":"7","key":"1075_CR19","first-page":"421","volume":"38","author":"A Avellaneda Fernandez","year":"2012","unstructured":"Avellaneda Fernandez A, Perez Martin A, Pombo Alles G, Gutierrez Delgado E, Izquierdo Martinez M. Perception of rare diseases by the primary care physicians. Semergen \/ Sociedad Espanola de Medicina Rural y Generalista. 2012;38(7):421\u201331.","journal-title":"Semergen \/ Sociedad Espanola de Medicina Rural y Generalista"},{"key":"1075_CR20","unstructured":"Orphanet. The portal for rare diseases and orhpan drugs. [Consulted 09\/20\/16]. Available from: http:\/\/www.orpha.net ."},{"key":"1075_CR21","unstructured":"Rare Disease Organisation (RaDiOrg). De stem voor alle mensen in Belgi\u00eb die getroffen worden door zeldzame ziekten. [Consulted on 10\/20\/16]. Available from: http:\/\/radiorgnl.squarespace.com\/ ."},{"issue":"3","key":"1075_CR22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijnurstu.2011.09.012","volume":"49","author":"B Dierckx de Casterle","year":"2012","unstructured":"Dierckx de Casterle B, Gastmans C, Bryon E, Denier Y. QUAGOL: a guide for qualitative data analysis. Int J Nurs Stud. 2012;49(3):360\u201371.","journal-title":"Int J Nurs Stud"},{"key":"1075_CR23","doi-asserted-by":"crossref","unstructured":"Britten N. Qualitative Interviews. Qualitative Research in Health Care: Blackwell Publishing Ltd; 2007. p. 12\u201320.","DOI":"10.1002\/9780470750841.ch2"},{"key":"1075_CR24","volume-title":"Jaarstatistieken met betrekking tot de beoefenaars van gezondheidszorgberoepen in Belgi\u00eb. FOD Volksgezondheid, Veiligheid van de voedselketen en Leefmilieu","author":"Cel Planning van het Aanbod van de Gezondheidszorgberoepen","year":"2015","unstructured":"Cel Planning van het Aanbod van de Gezondheidszorgberoepen. Jaarstatistieken met betrekking tot de beoefenaars van gezondheidszorgberoepen in Belgi\u00eb. FOD Volksgezondheid, Veiligheid van de voedselketen en Leefmilieu. 2015. Available from: http:\/\/overlegorganen.gezondheid.belgie.be\/nl\/documenten\/hwf-statan-2015-0 ."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1075-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1075-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1075-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T11:08:43Z","timestamp":1663412923000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1075-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,4]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1075"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1075-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,4]]},"assertion":[{"value":"13 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study, with protocol number S59783, was approved by the Medical Ethics Committee of UZ KU Leuven\/Research on the 30th of November 2016. Informed consent was obtained from all participants, including interviewed experts and physicians that completed the questionnaire.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests. All authors read and approved the final manuscript. Pfizer nv\/sa was not a sponsor of the study but provided support to Liese Vandeborne with access to their infrastructure, expertise and statistical aid during the conduct of this study. No undue influence from Pfizer nv\/sa was experienced on the presented work, and Pfizer nv\/sa did not receive any data obtained in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"99"}}